7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol has been researched along with Papilloma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilolikar, DS; Chen, JX; DiGiovanni, J; Harvey, RG; Morris, RJ; Slaga, TJ; Tang, MS; Viaje, A; Vulimiri, SV | 1 |
1 other study(ies) available for 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol and Papilloma
Article | Year |
---|---|
Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Biotransformation; Carcinogens; Codon; DNA; DNA Adducts; Epidermis; Female; Genes, ras; Mice; Mice, Inbred SENCAR; Mutation; Papilloma; Skin Neoplasms; Stereoisomerism | 2000 |